Literature DB >> 35765532

Melatonin Induced Schwann Cell Proliferation and Dedifferentiation Through NF-ĸB, FAK-Dependent but Src-Independent Pathways.

Navishaa Govindasamy1, Kian Chung Chok2, Pei Ying Ng3, Rhun Yian Koh4, Soi Moi Chye4.   

Abstract

Background: Peripheral nerve injury (PNI) is a common condition that compromises motor and sensory functions. Peripheral nerves are known to have regenerative capability and the pineal hormone, melatonin, is known to aid nerve regeneration. However, the role of Schwann cells and the pathways involved remain unclear. Thus, the aim of this study is to identify the effects of melatonin on Schwann cell proliferation, dedifferentiation, and the involvement of nuclear factor kappa light chain enhancer of activated B cells (NF-ĸB), focal adhesion kinase (FAK) and proto-oncogene tyrosine-protein kinase, Src pathways in this process.
Methods: Schwann cells was treated with melatonin and its proliferation and dedifferentiation were identified using MTT assay and immunofluorescence staining for SRY (sex determining region Y)-box 2 (SOX2). Next, the protein expressions of NF-ĸB, FAK and Src pathways were identified by Western blot.
Results: MTT results confirmed increased proliferation of Schwann cells with melatonin treatment, and it was highest at 10 μM melatonin. Immunofluorescent staining revealed an increase in the green fluorescence staining for SOX2 in melatonin-treated cells, showing enhanced dedifferentiation. Western blot assay revealed melatonin increased phospho-NF-ĸB (PNF-ĸB), IKK-α, FAK (D2R2E), phospho-FAK (Tyr 576/577 and Tyr 397) protein expressions as compared with control. However, Src (32G6), Lyn (C13F9), Fyn, Csk (C74C1) protein expressions were not increased as compared with control.
Conclusion: Melatonin promotes Schwann cell proliferation and dedifferentiation via NF-ĸB, FAK-dependent but Src-independent pathways.

Entities:  

Keywords:  Dedifferentiation; Melatonin; Peripheral nerve injury; Proliferation; Schwann cells

Year:  2022        PMID: 35765532      PMCID: PMC9208554          DOI: 10.52547/rbmb.11.1.63

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  31 in total

Review 1.  Clinical uses of melatonin: evaluation of human trials.

Authors:  E J Sánchez-Barceló; M D Mediavilla; D X Tan; R J Reiter
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

2.  Pinealectomy exaggerates and melatonin treatment suppresses neuroma formation of transected sciatic nerve in rats: gross morphological, histological and stereological analysis.

Authors:  Mehmet Turgut; Yigit Uyanikgil; Meral Baka; Ayten Türkkani Tunç; Altuğ Yavaşoğlu; Mine Ertem Yurtseven; Süleyman Kaplan
Journal:  J Pineal Res       Date:  2005-05       Impact factor: 13.007

Review 3.  Molecular mechanisms in successful peripheral regeneration.

Authors:  Milan Makwana; Gennadij Raivich
Journal:  FEBS J       Date:  2005-06       Impact factor: 5.542

Review 4.  Peripheral regeneration.

Authors:  Zu-Lin Chen; Wei-Ming Yu; Sidney Strickland
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

5.  Traumatic peripheral nerve injuries: epidemiological findings, neuropathic pain and quality of life in 158 patients.

Authors:  Palma Ciaramitaro; Mauro Mondelli; Francesco Logullo; Serena Grimaldi; Bruno Battiston; Arman Sard; Cecilia Scarinzi; Giuseppe Migliaretti; Giuliano Faccani; Dario Cocito
Journal:  J Peripher Nerv Syst       Date:  2010-06       Impact factor: 3.494

6.  Comparison of the beneficial effect of melatonin on recovery after cut and crush sciatic nerve injury: a combined study using functional, electrophysiological, biochemical, and electron microscopic analyses.

Authors:  Yasemin Kaya; Levent Sarıkcıoğlu; Mutay Aslan; Ceren Kencebay; Necdet Demir; Narin Derin; Doychin N Angelov; Fatoş Belgin Yıldırım
Journal:  Childs Nerv Syst       Date:  2012-10-09       Impact factor: 1.475

7.  Regulation of peripheral myelination by Src-like kinases.

Authors:  Shireen Hossain; Gabriela Fragoso; Walter E Mushynski; Guillermina Almazan
Journal:  Exp Neurol       Date:  2010-08-07       Impact factor: 5.330

8.  Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination.

Authors:  Nam Le; Rakesh Nagarajan; James Y T Wang; Toshiyuki Araki; Robert E Schmidt; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-03       Impact factor: 11.205

9.  EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting.

Authors:  Simona Parrinello; Ilaria Napoli; Sara Ribeiro; Patrick Wingfield Digby; Marina Fedorova; David B Parkinson; Robin D S Doddrell; Masanori Nakayama; Ralf H Adams; Alison C Lloyd
Journal:  Cell       Date:  2010-10-01       Impact factor: 41.582

10.  Sox2 controls Schwann cell self-organization through fibronectin fibrillogenesis.

Authors:  Elen Torres-Mejía; Dietrich Trümbach; Charlotte Kleeberger; Ulf Dornseifer; Tanja Orschmann; Theresa Bäcker; Jara Kerstin Brenke; Kamyar Hadian; Wolfgang Wurst; Hernán López-Schier; Sabrina C Desbordes
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.